If you missed Carter’s testimony at the Senate hearing, “Feeding a Healthier America: Current Efforts and Potential Opportunities for Food is Medicine,” the replay is available here.

The hearing emphasized the importance of nutrition to reducing healthcare costs and national debt, as well as the connection to national security, economic performance and GDP; highlighting data on promising solutions that can be scaled to drive drastic improvements — from medically tailored meals to innovations in our nation’s food and agriculture systems.

Carter’s testimony focused on innovation and what we have learned from the thousands of companies we have reviewed at iSelect over the past decade. The companies iSelect invests in are developing and bringing to market technologies that have transformative potential. By harnessing the power of science, regulation, and innovation, Williams envisions a future where food is synonymous with health, fostering longevity, productivity, and societal well-being.

Here are a few recent examples of how our portfolio is driving innovation in Food and Health:

iSelect named as one of “The 10 most active VC investors cultivating agtech’s future” by Pitchbook

Pitchbook, a leading provider of private market data, recently included iSelect Fund in a list of “the 10 most active VC investors betting on agtech to transform the future of food since 2019,” based on the number of agtech investments during that time.



Regenerative Food & Agriculture

Food and Health

Health Technology


Holobiome Series Seed

Healionics Bridge to B

Miraterra Series A

One.Bio Convertible Note

Agriwebb Bridge to Series C

Growers Edge Bridge to Series C

Geneoscopy Bridge to Series C

Cyrus Biotechnology Bridge to Series C

Immunophotonics Bridge to C

Arable Bridge to D

Vive Crop Protection Series C Extension

Bonumose Series C

Private investments are highly illiquid, speculative, can lose all value and are not suitable for all investors. Past performance is not indicative of future results. This message is not an offer to sell or the solicitation of an offer to buy any security, which only can be made through official offering documents that contain important information about risks, fees and expenses. Investment information contained herein has been secured from sources iSelect believes are reliable, but we make no representations or warranties as to the accuracy of such information and accept no liability. We suggest that you consult with a financial advisor, attorney, accountant, and any other professional that can help you to understand and assess the risks associated with any investment opportunity.

Securities offered through North Capital Private Securities, member FINRA/SIPC.